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The effect of cutaneous exposure to ultravio let B (UVB) 
rad iation alo ne, to crude coal tar (CCT) alone, and to the 
combination of UVB and CCT o n the inducibility of the 
microsomal cytochrome P-450-dependent carcinogen-
m etabolizing enzyme aryl hydrocarbon hydroxylase (AHH) 
and other m o nooxygenases such as 7-ethoxyresorufin 
O -deethylase (ERD) and 7-ethoxycoumarin O-deethylase 
(ECD) activities in the skin of neonatal rats was studied. 
Exposure of the an imals to UVB (400-1600 m]lcm 2) alone 
resulted in a dose-dependen t in crease in cutaneous enzym e 
activities. At a UVB dose of 1200 m]lcm 2 increases in 
AHH, ECD, and ERD were 194%, 115%, and 244% , 
respectively. A single topical application of CCT (10 mJ /kg) 
24 h before sacrifi ce resulted in significant indu ction of 
AHH (350%), ECD (921 %), and ERD (796%) activities. 
Treatment of anim als with the same dose of CCT followed 
by UVB exposure resulted in additive and /or synergistic 
effects o n AHH (858%), ECD (1229%), and ERD (1166%) 
activities in the skin . In contrast, exposure of animals to 
UVB prior to CCT application had effects no different 
fro m those of CCT alo ne. Epoxide hydro lase and gluta-
thione S-transferase acti vities in skin from all experimental 
groups were not different from those of controls. Hig h-
T he Goeckerman regimen is widely used for the trea t-ment of psori as is, a common dermatologic disease of the hum an population. T his modality consists of the appli ca ti on of va rious formul ations containing crude coa l tar (CCT) to skin followed by exposure to ul-
traviolet B (UVB) radiation [1 J, both of which are known to be 
ca rcinogenic for the skin of experimental animals and of humans 
[2,3]. It is now clea r that patients undergoing repeated Goeck-
erman therapy are at increased risk for the development of cu-
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Abbreviations: 
AH H : aryl hyd roca rbon hydroxylase 
BP: benzolaJpyrene 
CCT: crude coa l tar 
7-EC: 7-ethoxycoumarin 
pressure liquid chromatog raphi c analysis of the m etabolism 
ofbenzo[a]pyrene (BP) by cutaneous microso m es prepared 
from animals treated with UVB alone, CCT alo ne, and 
the combination of UVB and CCT revealed increased for-
matio n of all the metabolites in each experimental g roup . 
The larges t increase in m etabo lite formation occurred in 
animals receiving CCT followed by UVB exposure. The 
inducibility of trans-7, 8-diol form atio n by UVB alone and 
CCT alo ne was 203% and 435%, respectively , whereas 
with CCT followed b y UVB it was 1065% . The differ-
enti al respo nses in AHH activity were found to parallel the 
capacity of skin microsom al enzym es to enhance the bind-
ing of [3H]-BP to DNA. These studies indicate that the 
sequence of exposure to the components of the Goecker-
m an regimen in rodents g rea tly influences m atabolic acti v-
ity in skin. When applied in the sa m e sequence employed 
in the Goeckerman regim en (CCT followed by UVB ex-
posure) the additive effect upon ca talytic activity essential 
for cancer initiatio n sugges ts a possible m echanism for the 
enhancem ent of human skin cancer in individuals exposed 
to this therapeutic regimen. J Invest Dermatol 87:348-353, 
1986 
taneous cancer [4] whereas patients receiving intermittent infre-
quent courses of this modality have little or no enhanced risk of 
developing skin cancer [5] . Recent epidemiologic studies by Stern 
et al [6) confirm that psoriatic patients who receive multiple courses 
of Goeckerman therapy have an increased incidence of skin ca r-
cinoma compared to age- and sex-matched control populations. 
CCT is an exceedingly complex mixture of chemica ls that is 
ri ch in polycyclic aromati c hydroca rbons (PAHs), including 
benzol a )pyrene (BP) [7]. The carcinogenic and mutagenic effects 
EC D: 7-cthoxycoumarin O -deethylase 
E H : epoxide hydrolase 
E RD : 7-ethoxyresorufin O-dcethylase 
GSH : glutathio ne (reduced) 
GST: glu tathione S-transferasc 
HPLC: high-p ressure liquid chro matog raphy (-ic) 
NA DP H: nicotinamide adenine dinucleotide phosphatc (reduced) 
3-0HBP: 3-hydroxybenzola]py rene 
7-0HC: 7-hydroxycoum arin 
PAH: polycyclic aromatic hydroca rbon 
RF: resorufin 
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of CCT and certain of its co nstituent chemi ca ls in experim ental 
systems have been welJ documented (3,7-9). Saperstein and Wheeler 
(10] have demonstrated in vitro mutagenic respo nses to CCT. In 
subsequent studies Wheeler e t al (11] have shown th e presence of 
unidentified mutagenic substance(s) in the urine of patients trea ted 
with topicall y applied 5% CCT. Recent studies by Storer et al 
[12] have shown th at followin g to pical application of 2% CCT 
to the ski n of human volunteers certain PAHs including phenan-
threne, anthracene, pyrene, and fluoranthene ca n be identified in 
blood extracts. 
The ca rcinogenic PAHs themselves are relatively inert biolog-
ically and essentially act as precarcinogens that must first undergo 
metabolic activation by m ammalian enzy m es which convert them 
into th eir biologicall y active ultimate ca rcinogeni c metabolites 
[13-15]. These m etabo lites are hig hl y reactive, unstable moieties 
that can bind cova lently to cellular RNA, D N A, and proteins, 
as well as to syntheti c co polymers o f nucleic acids (1 3-15) . It is 
generall y agreed that the cova lent intera ction of reactive metab-
o lites of the PAHs with D NA m ay represent an essenti al initial 
s tep in tumor induction r1 3-15). Stud ies during th e pas t decade 
h ave identified o ne of the isomeric m etabolites o f BP known as ( + )-7,8, 8a-dih ydroxy-9a-1 Oa-epoxy-7, 8, 9 ,1 O-tetra h yd ro-
b enzo[a]pyrene as the ultim ate ca rcinogeni c species of this PAH 
(13-15] . The formation of this meta bolite is ca talyzed by 3 suc-
cessive enzy matic steps: first, hydroxy lation by aryl hydroca rbo n 
hydroxylase (AHH), a cytochrome P-450-dependent mixed- func-
tion oxidase, fo llowed by epoxide hydro lase (E H) and again by 
AHH [13-15]. T he reactive epoxide interm edi ates are detoxifi ed 
by conjugation with glutathione, a reactio n ca talyzed by g luta-
thione (GSH) transferases [13-15] . These enzy m atic pathways for 
the m etabolic activation and inactivation ofPAHs have been iden-
tified in the skin [16,17] . 
Studies from our laboratory have shown that topi ca l application 
of CCT to an imals (18-20) and to hum ans [21] results in the 
induction o f cutaneous AHH activity. We have recentl y shown 
that the use of CCT -co ntaining shampoo induces AHH activity 
and the DNA binding of PAHs in human hair fo llicles [22]. 
Highly inducible AHH activity appea rs to co rrelate with enhanced 
risk of tumor susceptibility to PAHs in several inbred mo use 
s trains [23J. Since each of the m aj or components of the Goeck-
erm an regimen (CCT and UV B) are known to be ca rcinogenic 
in mammalian skin w e wondered whether th e combination mi ght 
have an effect upon carcinogen metabolism. In the study described 
h ere, w e have attempted to mimic the Goeckerman therapy of 
psoriasis in the skin of experimenta l anim.als. Our results indicate 
that skin exposure to the components of th e Goeckerman regi-
men , in the sequence in which they are used therapeutically, ma y 
have an additive en hancing effect o n the metabolic activation o f 
PAH carcinogens that could explain th e ca ncer-causin g effect of 
this reg imen . 
MATERIALS AND METH ODS 
Chemicals 3H-Labeled BP-4,5-oxide (sp act 289 m C i/ mmol) 
and unlabeled BP-4,5-oxide were provided by the Cancer Re-
search Prog ram of the National Cancer Institute, Divisio n of 
Cancer Cause and Prevention (Bethesda , Mary land). [G-
3H]Benzo[a]pyrene (sp act 25 Ci/mmol) and [7, 10-14C]BP (sp act 
58.5 mCi / mmol) were purchased from Am.ersham Searle (Chi-
cago , Illinois). Go ld label BP, 7-ethoxycoumarin (7-EC) 7-hy-
droxycoumarin (7-0HC) , resorufin , and phenol (>99% pure) 
were obtained from Aldrich C hemica l Co. (Milwaukee, Wiscon-
sin) . 7-Ethoxyreso rufin was a product of Pierce C hemicals . Pro-
tease (Type XI) , m-cresol, 8-hydroxyquino line, nicotinamide ad-
enine dinucleotide phosphate (reduced) (NADPH), calf thymus 
DNA, and ribonuclease A (Type III-A) w ere purchased from 
Sigma Chemical Co. (St. Louis, Missouri). Standard coal tar 
solution (USP) was used. All other chemicals w ere obtained from 
commercial sources in the purest form ava ilable. 
Radiation Source The UVB radi ation source consisted of a 
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bank of4 Wes ting house FS-40-T- 12 flu orescent sunl amps which 
delivered an average of 3.0 ] /cm 2/s o ver the wavelength range 
290- 315 nm . Dosimetry of the rad iat io n source was calibrated 
week ly with an Internati onal Lig ht Spectroradiometer System (IL 
700/760/780) containing a PM 270 D-CM 149 detector with a 
spectral range of 240-81 0 nm. 
Animals Sperm-positive pregnant Sprague-Dawley rats of known 
insemination date w ere o btained from the Holtzm an Rat Farm 
(Madison, Wisconsin). N eonatal rats bo rn in situ were allowed 
to suckle until day 4 after birth ; they were then withdrawn from 
their mothers and used in these experiments. The ad vantages of 
using neonatal rodents for stud ies o n cutaneous drug and ca rcin-
ogen meta bo li sm have been described previously [17 ,18]. 
Treatment of Anin'lals In each experim ent 120 neonata l rats 
were di v ided into 6 g ro ups o f 20 each, and treated in the followin g 
m ann er: grollp 1 received a sing le to pica l treatment of acetone (10 
mllkg) and served as control, grollp 2 received UVB alo ne (1200 
m] /cm 2), group 3 received a single topica l appli ca ti on of CCT 
alone (1 0mllkg), group 4 received UVB followed immedi ately by 
CCT, group 5 received UVB foll owed by acetone (this gro up was 
considered necessa ry beca use an im als in group 6 received CCT 
fo llowed by UVB) , and group 6 received CCT followed by UVB. 
Fo r th e UVB exposures animals were exposed to the radiation 
source fo r a period of 4 h to deliver the desired dose. Each treat-
ment was designed in such a way that all animals were killed 24 
h after receiving CCT o r aceto ne. T he dose of CCT was selected 
based o n its m aximum enzym e induction effects r1 8-20]. T he 
UVB dose selected was based on its own m aximal inducing effects 
(sec Fig 1) . 
Enzyme Assays Ary l hydroca rbo n hydroxy lase activity in cu-
taneous mi croso mes was determined by a m odification of the 
method of N ebert and Gelbo in [24], the details of w hi ch have 
been described ea rlier [1 6, 17]. T he quantitation or pheno lic BP 
metabolites was based o n comparison with the flu o rescence 
of a standard so lutio n of 3-hyd roxybenzo laJpyrene (3-0HBP). 
7-E thoxycoumarin O-deethylase (ECD) activity was determined 
acco rding to a slig ht m odifi cati o n of the proced ure of G reenlee 
and Poland [25], the details of w hich have been described ea rlier 
[16, 17] . The am o unt of the product formed was calcul ated in 
comparison with an authentic standard of 7- 0HC. 7-Ethoxyre-
sorufll1 O-deethylase (ERD) acti vity was determined by a m od-
ifi ca tio n of th e method of Po hI and Fo uts [26J, the details of w hich 
were described ea rlier [27J . Quantitation of the deethylated me-
tabolite w as based on co mpariso n w ith the flu orescence of a stan-
dard so lutio n of reso rufin (RF). E poxide hydrol ase acti vity in the 
microso mal fractions was assayed using BP-4,5-oxide as substrate 
according to the thin-la yer chro m atographic technique of Jerina 
et al (28), th e details of which were described previously (1 6). 
Cytosolic GS H-transferase activity was assayed w ith BP-4,5-ox-
ide as substrate as described previo usly [1 7]. Protein was deter-
mined , after precipitation w ith trichl o roaceti c acid , by the pro-
cedure of Lowry et al [29] using bovine seru m albumin as a 
reference standard. 
In Vitro BP-DNA-Binding Studies The incubation sys tem 
for th e in vitro (3H]_BP DNA-binding studies was similar to that 
described by Hesse et al [30J. After incubatio n , the reaction mix-
tures were centrifuged at 105,000 g to isolate the mi crosomes, 
and diges ted with sodium dodecy l sul fa te to extract any traces of 
pro tein . T he extracti on procedure was similar to that described 
by Lesca et al (31 J. D etails of th ese procedures were described 
earlier [32]. Extracted ca lf thymus DN {\ was then dissolved in 5 
1111 of 0. 1 M sodium chl o rid e, pH 7.0, and es timated by measuring 
its absorptio n at 260 nm . The purity of the DNA was assessed 
by the absorbance ratios of A 260/280 ~ 1.98 and A 260/230 ~ 
2.21 (33]. Aliguo ts of extracted DNA were co unted on a Packard 
TriCarb 460 CD liquid scintill ation spectrometer to determine 
th e amount of (3H)_BP covalentl y bound to calf th ymus DNA. 
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Figure 1. UVB dosimetry for studies on cutaneous monooxygenase ac-
tivities. Animals were exposed using a bank of 4 Westinghouse FS-40-
T-12 flu orescent sunlamps at a distance of9 inches to deliver the dosage 
indica ted . Following UVB exposure animals were immediately killed and 
skin microsomal fractions prepared and enzyme activities determined . 
Opel'l diamonds, ECD; solid diamonds, AHH; solid squares, ERD. Data rep-
resent mean of 4 different preparations. For each preparation 20 neonatal 
rats were pooled. 
In Vitro Incubation System for BP Metabolism The in-
cubation mixture in a fin al volume of 1.0 ml contained 0.5 mg 
skin microsomal protein (prepared from control or treated ani-
mals), 0.10 mmol of phosphate buffer, pH 7.4, 3 /Lmol of MgCb 
and 1. 3 /Lmol of NADPH. The reaction was initiated by the 
addition of 80 nmol of [' 4C]BP in 40 /LI acetone . The samples 
were incubated for 30 min in the dark at 3rC in a Dubnoff 
metabolic shaker. The reaction was terminated by the addition 
of 1 ml of cold acetone followed by 2 ml of ethyl acetate. The 
ITlixture was vortexed for 1 min to extract any un reacted BP as 
well as the metabolites into the organic phase. The organic and 
aqueous layers were separated by centrifugation at 1500 rpm for 
10 min. The radioactivity in the aqueous phase ranged from 
0.03-0.4% of the total radioactivity and was proportional to the 
extent of BP metabolized. The organic phase was dried under a 
stream of nitrogen and dissolved in 100 /LI of methanol for high-
pressure liquid chromatographic (HPLC ) analysis as described 
earlier [32] . All operations were performed under yellow light. 
High-Pressure Liquid Chromatographic Analysis of For-
mation of Metabolites A Waters Associates Model 204 liquid 
chromatograph, fitted with a Waters Associates C's /LBondapak 
column (4.6 mm X 25 cm) was used for the analysis of radio-
labeled metabolite mixtures of BP. Identification of metabolites 
was based on reference standards. The column was eluted at 
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ambient temperature with a 30-min linear gradient of metha-
nol:water:tetrahydrofuran (40:27:3, v /v) to methanol at a solvent 
flow rate of 0.8 ml/min [34]. The eluates were monitored at 254 
nm, fractions of approximately 0.2 ml were collected dropwise, 
and the radioactivity of each fraction was determined on a Packard 
Tri-Carb 460 CD liquid scintillation spectrometer. 
Statistical Analysis The statistical significance of differences 
between control and treated animals were evaluated by the Stu-
dent's i- test. A p value of 0.05 or less was considered as statistically 
significant. 
RESULTS 
Effect of Skin Exposure to UVB on Cutaneous Monoox-
ygenase Activities The effect of exposure of animals to varying 
doses of UYB alone on cutaneous AHH, ECD, and ERD activ-
ities is shown in Fig 1. Ultraviolet B exposure alone resulted in 
dose-dependent increases in all 3 monooxygenase activities. At a 
UYB dose of 1200 mJ!cm2 increases in ERD, AHH, and ECD 
activities were 244%, 194%, and 115% as compared with control 
animals kept in the dark. Since there appears to be a plateau or 
decline in enzyme activities beyond a UYB dose of1200 mJ/cm2 
this was selected for further studies . 
Effect of Exposure of Animals to UVB and CCT, Alone 
and Combined, on Cutaneous Monooxygenase, EH and 
Glutathione S-Transferase (GST) Activities The effect of ex-
posure of animals to UYB and CCT, alone and combined, on 
cutaneous AHH, ERD, and ECD activities is shown in Table 1. 
All 3 monooxygenase activities in skin were found to be induced 
by the exposure of animals to UVB alone (127-167%) and CCT 
alone (350-921 %). Cutaneous exposure to UYB followed by 
treatment with CCT was no more effective than exposure to CCT 
alone. The treatment of animals with acetone followed by ex-
posure to UYB (group 5) was slightly less effective than UVB 
exposure alone. Nevertheless, in each case there was statistically 
significant induction as compared with the enzyme activities in 
unexposed animals. CCT treatment followed by UYB exposure 
(group 6) produced maximum inducing effects on enzyme activ-
ities . The observed enzyme induction effects by the combination 
of CCT follow ed by UVB were either additive or synergistic. 
Cutaneous exposure to UVB alone and treatment with CCT alone 
resulted in 127% and 350% increases, respectively, in AHH ac-
tivity. However, in those animals where CCT treatment was 
followed by UVB exposure, the observed increase was 858% as 
compared with untreated animals. The increase in AHH activity 
in this group when compared with those exposed to UVB alone 
or to UYB followed by acetone was 322% and 412%, respec-
tively . These responses in enzyme activities were quite similar to 
those observed in animals receiving CCT treatment alone (350%). 
Similar patterns of effects were observed for ERD and ECD 
activities . Cutaneous EH and GST activities remained unchanged 
Table I. Effect of UYB and CCT, Alone and Combined, on Cutaneous Monooxygenase Activities in Neonatal Rats 
AHH Activity ERD Activity ECD Activity 
pmol pmol pmol 
3-0HBP/min/mg Percent Increase RF/ min /m g Percent Increase 7-HClmin/ mg Percent Increase 
Treatment Protein over Contro l Protein over Control Protein over control 
Cont ro l 1.75 ± 0.12 1.92 ± 0.14 0.34 ± 0.01 
UVB alone 3.97 ± 0.34" 127 4.64 ± 0.27" 142 0.89 ± 0.07" 162 
CCT alone 7.85 ± 0.66 350 17.20 ± 2.41b 796 3.47 ± 0.25/' 921 
UVB + CCT 8.00 ± 0.64b 358 17.89 ± 2.84/' 832 3.67 ± 0.27b 979 
UVB + acetone 3.27 ± 0.21" 87 3.59 ± 0.31" 87 0.82 ± 0.08" 141 
CCT + UVB 16.74 ± 1.06' 858 24.30 ± 2.97' 11 66 4.52 ± 0.34' 1229 
Data represent mean :t SEM of 4 separate experiments. Enzyme activities in control (acetonc-treatcd) gro up were no different from the untreated group. For treaunent 
conditions scc Materials alld Methods. 
"S tatisti ca ll y significant from control (p < 0.01). 
'Statistica lly significant fro m control and from UVB (p < 0.01). 
'Statisticall y signifi cant from control. from UVB and from UVB + CCT (p < 0.01). 
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Table II. Effect of UVB and CCT, Alone and Combined, 
on Cutaneous Microsomal Enzyme-Mediated Binding of 
[3H]BP to Calf Thymus DNA 
Treatment 
Contro l 
UVB alone 
CCT alone 
UVB + CCT 
UVB + acetone 
CCT + UVB 
Covalent Binding 
(pmol [3H]BP/ mg DNA) 
3.84 :±: 0.24 
6.96 ± 0.61" 
10.10 ± 1.1 61' 
10.77 :±: 1.12b 
5.29 ± 0.26" 
12.86 ± 1.44' 
Data represent mean ± SEM of 4 separate experim ents. 
· Statistically significant from control (p < 0.01) . 
Percent Increase 
over Control 
81 
163 
180 
38 
235 
' Statistically sign ificant from control and from UVB (p < 0.0 1). 
'Statistically significant from control, from UVB, and fro m UVB + CCT 
(p < 0.0 1) . 
following exposure of animals to UVB alone, to CCT alone, or 
to the combination of these 2 modalities (data not shown). 
Effect of Exposure of Animals to UVB and CCT, Alone 
and Combined, on Cutaneous Microsomal Enzyme-Me-
diated Binding of [3H]BP to DNA Skin microsomes pre-
pared from animals treated with UVB alone and CCT alone 
caused 81 % and 163% increases, respectively, in the binding of 
e H]BP to ca lf thymus DNA as compared with microsomes pre-
pared from control animals (Table II) . Microsomes prepared from 
the skin of animals exposed to UVB followed by treatment with 
CCT resulted in a 180% increase in macromolecular binding. 
This increase in the binding activity w as not different from that 
of CCT trea tment alone. Consistent with the effects observed on 
monooxygenase activities, treatment of animals with topically 
applied CCT followed by UVB exposure resulted in the highes t 
increase (235%) in the binding of[3H]BP to calf thymus DNA. 
Effect of Exposure of Animals to UVB and CCT, Alone 
and Combined, on Cutaneous Microsomal Metabolism of 
BP In further experiments , the effect of exposure of animals to 
UVB and CCT, alone and combined, on the pattern of skin 
microsomal metabolism of BP was assessed. The quantitation of 
BP metabolites was studied using HPLC analysis. As shown in 
Table III, skin exposure of animals to UVB alone resulted in an 
overall 121 % increase in formation of BP metabolites . Treatment 
of animals with CCT alone resulted in 352% increased formation 
of BP metabolites. Exposure of animals to UVB followed by 
CCT treatment had effects no different from that of CCT treat-
ment alone. However, topical application of CCT followed by 
exposure to UVB resulted in the highest enhancement of BP 
metabolite formation. The increase in BP metabolite formation 
by skin microsomes prepared from groups of animals treated with 
CCT followed by UVB was 834%, 322%, and 373%, respec-
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Figure 2. Effect of UVB and CCT, alone and combined, on gcneration 
of specific mctabolites ofB P by cutaneous microsomal enzymes. For other 
details see Ma terials alld Meth ods. 
ti vel y, as compa red with the control group , and groups treated 
with UVB alone, and w ith UVB followed by acetone. As shown 
in Table III , formation of diols, quinones , and phenols increased 
similarl y . Formation of BP-lralls-7,8-diol, the precursor of the 
ultimate carcinogenic metabolite ofBP [13-15]. increased 1065% 
in skin microsomes prepared from animals treated w ith CCT 
followed by UVB exposure as compared with untreated controls 
(Fig 2). This increase was higher than that occurrin g for any other 
metabolite. Interestingly, skin ex posure of animals to UVB alone 
resulted in the highes t increases in the formation ofBP-lralls-diols 
including BP-lralls-7,8-diol formation. This increase in diol for-
mation is significantl y higher than that which occurred for total 
metabolite formation (Fig 2) . 
DISCUSSION 
The skin is a major interface between th e body and its environ-
ment and is therefore at par ti cular risk for the development of 
malignancy. It is known that individuals repeatedly exp_osed to 
CCT and UVB employed in the Goeckerman regimen for pso-
ri as is are at increased risk for the development of cutaneous cancer 
but the reason for this is unknown [4). The major purpose of this 
stud y was to determine whether differences in the metabolism of 
ca rcinogenic PAHs could explain the enhanced skin tumorigeni-
city evoked by the combination of skin exposure to CCT and 
UVB radiation. While the individual cutaneous oncogenicity of 
CCT, and of UVB , are beyond dispute, there is a paucity of 
Table III. Effect of UVB and CCT, Alone and Combined, 011 C utaneous Microsomal Metabolism of BP in N eonatal Rats 
UVB + UVB + 
Metabolite" Control UVB Alone CCT Alone CCT Acetone CCT + UVB 
Tra'1S-9,10-diol 1.3 3.1 5.4 5.3 2.4 12.5 
Tratls-4,5-diol 4.7 9.8 18.4 16.4 8.6 54.3 
Tram-7,8-diol 4.0 12.1 (203) 21.4 (435) 20.8 (420) 9.4 (135) 46.6 (1065) 
1,6-Quinonc 17.2 36.4 79.7 72.5 32.4 162.7 
3,6-Quinonc 16.5 34.9 74.7 79.7 28.7 152.4 
6, 12-Quinone 22.4 48.9 98.6 100.4 44 .5 210.4 
9-0H 12.4 31.4 (123) 50.3 (353) 48.6 (372) 28.6 (108) 96.7 (783) 
3-0H 29.6 62.2 139.8 149.7 58.7 274.3 
Total metabolites 108. 1 238.8 (121) 488.3 (352) 493.4 (356) 213.3 (97) 1009.9 (834) 
·Picomoles of metabolite formed/3~ min/mg protein. Eighty nmol I14CJBP (51' act 58.5 mCil l11l1Jol) were incubated w ith skin microsomes (0.5 mg protein) in a final 
volume of 1.0 ml. Nunlbcrs shown are average values of triplicate samples which agree within 10% o Cthe indicated values. These values w ere w ithin 10-200/0 oCthe val ues 
obta ined from experiments using different skin microso mal preparations . Other details arc provided in Malel'ials alld Meth ods. Percent increase over co ntro l is given i,1 
parfllrheses. 
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knowledge concerning the m anner in w hich these 2 carcinogens 
interact to evoke cancer in the skin . 
C rude coal tar is a complex mix ture o f chemica ls generated by 
th e destru ctive di still ation of coal. It contains thousands o f chem-
icals some of which are PAHs, o f which several are known to be 
ca rcinogenic probabl y because o f their ability to structura.ll y m od-
ify DNA. Similarl y UVB radiation is ca rcinogeni c and this m ay 
also be fo r the sa me reason. T he effect o f expos ure of human and 
rodent skin to CCT on cutaneous carcinogen matabo lism has 
been studied . Bickers and Kappas [21] showed that CCT is ca-
pable of inducing human skin AHH in vivo and that th e induction 
response varies som ewhat am ong individuals, perh aps on a ge-
netic basis. O ur subsequent studies [1 8] have dem onstrated th at 
CCT applied topically to neonatal rats can induce cutaneous and 
extracutaneous AHH activity. In addition, topical application of 
CCT to anim als results in the induction of hepatic EH acti vity 
and cytochrome P-450 levels [20]. In ano th er study , Mukhtar et 
al [1 9] evaluated the effects o f topica l appli ca ti on of a number o f 
defin ed constituent PAHs present in a standard CCT mixture for 
their ca pacity to m odulate cutaneous and hepati c dru g and car-
cinogen m etabo lism . T hese studies indica ted th at several PAHs 
present in coal tar have induction effects on dru g and ca rcinogen 
metabolism in skin and liver and that th ere are tissue-specifi c 
differences in res ponses to som e of these hydrocarbons. Since the 
inducibility o f AHH in target tissue appears to co rrelate w ith 
tumor inducti on in that tissue, th e observation th at CCT could 
induce cutaneous AHH is consistent w ith data indica tin g that 
CCT is carcinogenic for skin. 
Excessive sun exposure is also known to be a causa ti ve facto r 
in human skin cancer as first proposed by Unna in ] 894 [35] . He 
recognized tha t neoplas m s occurred in the preferentiall y chron-
icall y sun-exposed skin of sa il o rs. C lass ical studies in experimental 
animals by Blum defm ed the carcinogenic action spectrum as 
being almos t exclusively in the UVB ran ge of 290-320 nm [36]. 
These wavelengths are at the lower, m ore energeti c end of the 
solar spectrum th at reaches th e surface of the ea rth . Numerous 
investigators have cl earl y shown that rodents offer an excellent 
experimental animal model for studies ofUV skin ca rcinogenesis 
[2]. Furthermore the initiati on-pro motion concept o f chemical 
carcinogenesis is also applica ble to UV carcinogenesis. Thus, it 
has been shown that a sing le dose of UV radi ation followed by 
croton oil promotion produces skin tum ors in hairless mi ce [37] . 
Although there are some differences in the biologic behavio r o f 
UV -induced skin tumo rs as compared w ith chemically induced 
cutaneous lesions, th e initiatio n and promotion concept o f car-
cinogenesis appea rs to be valid fo r both CCT and UV tumori-
genesIs. 
Very few studies have been conducted to assess the effects o f 
UV radiation on drug and ca rcinogen metabolism in skin o r other 
tissues o f experimental animals. Tredger and C hhabra [38], while 
stu dyin g dru g metabolism in liver and intestin e, observed cir-
cadian variations in enzyme activities . T hey postulated that the 
light cycle could be related to these circadian changes. Pohl and 
Fouts [39] found increased ECD acti v ity in the skin of fem ale 
hairless mice exposed to short-wave UV radiati on (254 nm) and 
to a sunlamp (280-750 nm) . Goerz et al [40] exposed fem ale 
hairless N g/ mice to UV radi ation fo r 16 h daily fo r a period of 
24 weeks (mean daily doses: UVA = 106 J/c m 2, UVB = 0.62 
J/c m2), and observed increases in the acitivities o f AHH, ami-
nopyrine N-demethylase, ECD , and in the contents o f the cy-
tochro me P-450 in liver o f exposed animals. H ow ever, these 
in ves ti gato rs detected no effect o f such exposure on skin enzy me 
activity. 
The manner in w hich chemical agen ts m ay influence UV car-
cinogenesis is a subj ect o f considerable interes t. Such agents in-
clude chemical pro m oters, pho tosensitizers, and ca rcinogens. A 
number o f substances including CCT and select PAHs present in 
CCT are bo th pho to toxic and ca rcinogenic. In 1937, Bungeler 
[41] observed that by injecting tar subcutaneously into w hite mice 
prior to expos ure to sunlight the yield o f bo th benign and ma-
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lignant tum ors w as g reatl y increased . Urbach [42] demonstrated 
that CCT enhanced the number o f ea r tumors fro m carefull y 
m easured mid wa velength(280- 360 nm) exposure. 
Several inves tigato rs have exa mined th e effects of combined 
trea tment o f UV radi ation and chemicals, including tar, on tumo r 
development in experim ental animals. Findlay [43] painted a sm all 
area of depilated m ouse skin prio r to exposure to a quartz mercury 
va por lamp 4 times a week . In these studies skin can cers developed 
m ore rapidl y in mi ce so trea ted than in mi ce treated w ith ta r 
alone. Subsequent inves ti ga to rs o btained confli ctin g results from 
similar studies . E xperim ents in w hich skin painting with BP [44] 
o r 20-meth ylcholanthrene [45] was followed by exposure to vis-
ibl e light o r in w hi ch topical applica tion of BP, dimethylbenza-
thracene, and 20- m eth ylcholanthrene w as fo ll ow ed by UV ra-
di ation [46] have either fa iled to dem onstrate an in crease in 
ca rcinogenesis o r have resulted in fewer tumors th an did the 
chemical ca rcinogen alone. O ther w orkers have repo rted in-
creased [47], decreased [48], or no effect [49,50] from studies o n 
the combination o f UV radiation and P AH . N one of th ese studies 
has attempted to mimic Goeckerman therapy in assessing the 
interacti on of UV radi ation and PAHs on skin can cer fo rmation . 
O ur data indicate that bo th UVB alone and CCT alone each 
substantiall y enhances cutaneous microso m al cytochrome P-450-
dependent AHH, ECD , and E RD activities. Of the 3 monoox-
ygcnases studied , ERD is specifi ca lly dependent upon cytochrome 
P-448. In general, the specificity for cytochrom e P-448 is in the 
o rder o f ERD > AHH > E C D . It is interestin g to no te from the 
data in Fig 1 that the degree of observed increases in enzym e 
acti vity follow ed the specifi city of cytochrom e P-448. It is im-
portant to emphasize that this isoenzym_e o f cytochrome P-450 
participates in the activation of m any precarcinogens to their ul-
timate carcinogeni c m etabolite. In addition our data indicate that 
bo th UVB alone and C CT alone substantially enhance the m e-
tabolism of the carcinogenic P AH, BP, and the binding of m e-
tabolites of BP to epidermal DNA. When CCT was applied to 
skin previously irradiated with UVB additive effects w ere ob-
served on these param eters in skin . T hese results indicate that 
exposure of rodent skin to CCT follow ed by UVB radiation 
additively augm ents the effect of each on ca rcinogen m etabo lism 
thought essential for tumor induction. Perhaps irradiation of CCT-
treated skin yields larger am ounts of reactive m etabolites of PAHs. 
Pretrea tment with UVB foll owed by CCT does not exhibit ad-
ditive effects. The explanation fo r this m ajor di fference ma y relate 
to pho tochemi cal changes produced in skin by UVB which some-
how alters the cutaneous response to CCT . It remains to be seen 
whether grea ter increases in skin AHH and o th er parameters fol-
low ing cutaneous treatment with C CT follow ed by exposure to 
UVB results in increased carcinogeni city than that occurring with 
CCT treatment alone . These studies are currently under w ay in 
our labo rato ry. 
T hallks are dll e to Mrs . Sam/ra E 'laIIS for preparillg the ilia/II/script alld to Mr. 
Dar/iel P. Bik fo r technica l ass istallce. 
REFERENCES 
1. Goeckerman WH : T reatment of psoriasis: continued observa tions 
on the use of coa l tar and ultraviolet light. Arch Dermatol 
24:446-450, 1931 
2. Emm ett EA: Ul traviolet radiation as a cause of skin tumors. CRC 
Crit Rev Toxicol 2:211 -255 , 1973 
3. Henry SA: Occupational cutaneous cancer attributable to certain 
chemicals in industry. Br Med Bull 4:389-401, 1947 
4. Stern RS, Zicrler S, Parrish JA: Skin carcinoma in patients with 
psorias is treated with topical tar and artifi cial ultraviolet radiation. 
Lancet 2:732-733, 1980 
5. Epstein JH: Risks and benefits of the trea tment of psoriasis. N Engl 
J Med 300:852-853, 1979 
VOL. 87, NO.3 SEPTEMBER 1986 
6. Stern RS, Scotto J , Fears TR: Psoriasis and susceptibility to non-
melanoma skin cancer. J Am Acad Dermatol 12:67-73, 1985 
7. Repor t on Coal Tar. National Institute for Occupationa l Safety and 
Health Publica tion, Washington, DC, 1977 
8. Rasmussen JE: The crudeness of coal tar. Prog Dermatol 12:23-29, 
1978 
9. Kipling DM: Soots, tars, and o ils as causes of occupational cancer, 
C hem ica l Ca rcinogens. Edited by CE Sea rl e. Washington, DC, 
American Ca ncer Society , 1976, pp 3 15-323 
10. Saperstein MD , Wheeler LA: Mutagenicity of coa l tar preparations 
used in the treat ment of psoriasis. Toxicol Lett 3:325-329, 1979 
11. Wheeler LA , Saperstein MD, Lowe NJ: Mutagenici ty of urine fro m 
pso riat ic patients undergoing treatment w ith coal tar and ultra-
violet light. J Invest Dermatol 77:1 8 1- 185 , 1981 
12. Storer JS , DeLeon I, Millikan LE, Laseter JL, Griffing C: Human 
absorption of crude coal tar products. Arch Dcrmatol 120:874-877, 
1984 
13. Conney AH: Induction of microso mal enzymes by foreign chemi cals 
and carcinogenes is by polycyclic aromatic hydrocarbons: GH A 
C lowes Memorial Lecture. Cancer Res 42:4875-4917, 1982 
14. Heidelberger C: C hemica l carcinogenesis. Annu Rev Biochem 
44:79-121 , 1975 
15. Gelboin HV: Benzo(a)pyrene metabo lism, activa tion and carcino-
genesis: role of regulat ion of mixed-function oxidases and related 
enzymes. Physiol Rev 60: 1107-11 66, 1980 
16. Bickers DR, Dutta-Choudhury T, Mukhtar H : Epidermis: a site of 
dru g metabolism in neonatal rat skin . Studies on cytochrome 
1'-450 content and mixed function oxidase and epoxide hydrolase 
activity. Mol Pharmacol 21:239-247, 1982 
17. Mukhtar H, Bickers Dn: Drug metabolism in skin : co mparative 
activity of the mixed function oxidases, epoxide hydrolase, and 
glutathione-S-transferase in liver and skin of neonatal rat. Drug 
Metab Dispos 9:311-314,1981 
18. Bickers DR, Wroblewski D, Dutta-C houdhury T, Mukhtar H: In-
duction of neonatal rat sk in and li ve r ary l hydroca rbon hydrox-
ylase by coal tar and its constituents. J Invest Dermatol 78:227- 229, 
1982 
19. Mukhtar H, Link C M, C herniack E, Kushner DM, Bickers DR: 
Effect of topical applica tion of defin ed constituents of coal tar on 
skin and liver aryl hydrocarbon hydroxylase and 7-ethoxycou-
marin dee th ylase activities. Toxicol Appl Pharm acol 64:541-549, 
1982 
20. Mukhtar H , Bickers Dn: Evidence that coal tar is a mixed inducer 
of microsomal drug metabolizing enzymes. Toxicol Lett 11 :221-227, 
1982 
21 . Bickers DR, Kappas A: Human skin ary l hydroca rbon hydroxylase: 
induction by coal tar. J C lin Invest 62:1 061-1 068, 1978 
22. M erk HF, Mukhtar H, Bickers Dn: Hum an hair follicle: access ible 
tissue source for measuring enzyme-mediated DN A-binding of 
chemical ca rcinogens. C lin Res 32:482, 1984 
23. N ebert DW, Goujon FM, GiclenJE: Aryl hydrocarbon hydroxylase 
induction by polycyclic hydrocarbons- simple autosomal domi-
nant trait in the mouse. Nature 236:107-110, 1972 
24. Nebert DW, Gelboin HV: Substrate inducible microsomal aryl hy-
drocarbon hydroxylase in mammalian cell culture. I. Assay and 
properties of induced enzyme. J B io i C hem 243:6242-6249, 1968 
25. Greenlee WF, Poland A: An improved assay of 7-ethoxycoumarin 
O-deethylase activity: induction of hepatic enzyme activity in 
C57B Ll6J and DBA/2J mice by phenobarbital, 3-methylcholan-
threne, and 2,3, 7,8-tetrachlorod.ibenzo-p-dioxin . J Pharmacol Exp 
Ther 205:596-605, 1978 
26. Pohl RJ, Fouts JR: A rapid method for assaying the metabo lism of 
7-ethoxyresorufin by microsomal subcellular fractions. Anal 
Biochem 107:150-155, 1980 
27. Asokan 1', Das M , Rosenkranz HS, Bickers DR, Mukhtar H : Top-
ically applied nitropyrenes are potent inducers of cutaneous and 
hepatic monooxygenases. Biochem Biophys Res Co mmun 
129: 134-140, 1985 
CARCIN OGEN METABO LISM AND GOECKERMA N THERAPY 353 
28 . Jerina DM, Dansette PM, Lu A YH, Levin W: Hepatic microsomal 
epoxlde hyd rase: a sensi ti ve radiometric assay for hydration of 
arcne oxides of ca rcinogenic aromatic hydrocarbons. Mol Phar-
macol 13:342-351, 1977 
29. Lowry O H , Rosebrough NJ, Farr AL, Randall RJ: Protein mea-
surement w ith the Folin phenol reagent. J Bioi C hem 193:265- 275 
1951 ' 
30. Hesse S, Jernstrom B, M artinez M , M oldeus P, C hristodouIides L, 
Ketterer B: Inactiva tion of DN A-binding metabolites of 
benzo(a)pyrene and benzo(a) pyrene-7,8-dihydrodiol by glutathi-
one and glutathione-S-transferases. Carcinogenesis 3:757-760, 1982 
31. Lesca 1', Guenthner TM, Oesch F: M odulation of the covalent bind-
ing of aryl hydrocarbon meta bolites to DNA in vitro after trea t-
ment of rats and mice w ith trans-stilbene oxide. Ca rcinogenesis 
2: 1 049-1056, 1981 
32. Mukhtar H , Del Tiro BJ Jr. Das M , Cherniack EP, C herniack AD, 
Bickers DR: C lotrimazole, an inhibi tor of epidermal benzo(a)pyrene 
metabolism and DNA binding and ca rcinogenici ty of the hydro-
carbon. Cancer Res 44:4233-4240, 1984 
33. Ashurst SW, Cohen GM: T he fo rmation of benzo(a)pyrcne-deoxy 
ribonucleoside adducts ;/1 vivo and ;/1 vitro. Carcinogenesis 3:267-273, 
1982 
34. Bickers DR, Mukhtar H , Yang SK: C utaneous metabo lism of 
benzo(a)pyrene: comparative studies in C57BLl6N and DBA/2N 
mice and neonatal Sprague-Dawley rats. C hem Bioi Interact 
43:263-270, 1983 
35. Unna PG: The Histopathology of the Diseases of the Skin. Edin-
burgh, William FClay, 1896, p 719 
36. Blum HF: Carcinogencsis by Ultravio let Light. Princeton, NJ, Prin-
ceton Univ Press, 1959 
37. Epstein JH, Roth HL: Experim ental ultravio let ligh t carcinogenesis. 
A study of cro ton o il promoting effects. J In vest Dermatol 
50:387-400, 1968 
38. Tredger JM ,. C hhabra RS: C ircadian variations in microsomal drug-
metabohz111g enzy mc actlvmes 111 rat and rabbit tissues. Xenobi-
otica 7:481-489, J 977 
39. Pohl Rj , Fouts JR: Xcnobiotic metabolism in skin ~f hairless mice 
exposed to UV-rad iation (U V), Aroclor 1260, or chlo rdane. Phar-
macologis t 19:200, 1977 
40. Goerz G, Merck H , Boisen K, Tsambaos D , Berger H: Influence of 
UV -light exposure on hepatic and cutaneous monooxygcnases. 
Experentia 39:385-386, 1983 
41. Bungeler W: Uber den E influss pho tosensibilisierender Substantzen 
auf die Entstehullg von Hautgeschw ulston. Z Krebsforsch 
46:130-132,1937 
42. Urbach F: Modification of ultraviolet carcinogenesis by photoactive 
agents. J In vest Dermato l 32:373-378, 1959 
43. Findlay GM: Ultraviolet light and skin cancer. Lancet 2:1 070-1073, 
1928 
44. Morton JJ , Luce-C lausen EM, Mahoney EB: Visible light and skin 
tumors induced with benzopyrene in mice. Cancer nes 2:256-260, 
1942 
45. M ortonJJ, Milder GB , Luce-ClausenEM, Mahoney EB: The effect 
of visible light on the development in mice of skin tumors and 
leukemia induced by ca rcinogens. Cancer Res 11 :559-561, 1951 
46. Rusch HI' , Kline BE, Ba umann CA: The nonadditive effect of ul-
traviolet li ght and other carcinogenic procedures. Cancer nes 
2: 183-188, 1942 
47. MaisinJ , Dejonghe A: Au sujet de !'action de la lumiere et de !'ozone 
sur certains corps canccrigenes. C R Soc BioI (Paris) 11 7:114-119, 
1934 
48. Donaiach I, Mottra m JC: O n the effect of light on the incidence of 
tumors in painted mice. Am J Cancer 39:234-236, 1940 
49. Kohn Speyer AC: Effect of ultrav iolet radiation on the incidence of 
tar cancer in mice. Lancet 1:11 56-11 57, 1929 
50. Seelig M G, .Cooper ZK: Light and tar cancer: an experimental study 
WIth a crmcal revIew of the hteratu ie on light as a carcinogenic 
factor. Surg Gynecol Obstet 56:752-761, 1933 
